Clinical Trial Update: Molecular Phenotype Changes and Personalized Treatment for CRPC [NA]

View source ↗

Summary

This clinical trial update discusses molecular phenotype changes and personalized treatment strategies for castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Hormone Refractory Prostate Cancer | NA | Status: UNKNOWN